These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 16354004)

  • 21. The filling of molten and thixotropic formulations into hard gelatin capsules.
    Walker SE; Ganley JA; Bedford K; Eaves T
    J Pharm Pharmacol; 1980 Jun; 32(6):389-93. PubMed ID: 6106669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dissolution of a Biopharmaceutics Classification System Class II Free Acid from Immediate Release Tablets Containing a Microenvironmental pH Modulator: Comparison of a Biorelevant Bicarbonate Buffering System with Phosphate Buffers.
    Haznar-Garbacz D; Hoc D; Garbacz G; Lachman M; Słomińska D; Romański M
    AAPS PharmSciTech; 2022 Jul; 23(6):203. PubMed ID: 35882674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In-line ATR-UV and Raman Spectroscopy for Monitoring API Dissolution Process During Liquid-Filled Soft-Gelatin Capsule Manufacturing.
    Wan B; Zordan CA; Lu X; McGeorge G
    AAPS PharmSciTech; 2016 Oct; 17(5):1173-81. PubMed ID: 26604007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of formulation and process changes on in vitro dissolution and the bioequivalence of piroxicam capsules.
    Piscitelli DA; Bigora S; Propst C; Goskonda S; Schwartz P; Lesko LJ; Augsburger L; Young D
    Pharm Dev Technol; 1998 Nov; 3(4):443-52. PubMed ID: 9834946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In silico prediction of drug dissolution and absorption with variation in intestinal pH for BCS class II weak acid drugs: ibuprofen and ketoprofen.
    Tsume Y; Langguth P; Garcia-Arieta A; Amidon GL
    Biopharm Drug Dispos; 2012 Oct; 33(7):366-77. PubMed ID: 22815122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Roller compaction, granulation and capsule product dissolution of drug formulations containing a lactose or mannitol filler, starch, and talc.
    Chang CK; Alvarez-Nunez FA; Rinella JV; Magnusson LE; Sueda K
    AAPS PharmSciTech; 2008; 9(2):597-604. PubMed ID: 18459052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dry coating of soft gelatin capsules with HPMCAS.
    Cerea M; Foppoli A; Maroni A; Palugan L; Zema L; Sangalli ME
    Drug Dev Ind Pharm; 2008 Nov; 34(11):1196-200. PubMed ID: 18720149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The in vitro dissolution of theophylline from different types of hard shell capsules.
    Podczeck F; Jones BE
    Drug Dev Ind Pharm; 2002 Oct; 28(9):1163-9. PubMed ID: 12455475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Feasibility of biowaiver extension to biopharmaceutics classification system class III drug products: cimetidine.
    Jantratid E; Prakongpan S; Amidon GL; Dressman JB
    Clin Pharmacokinet; 2006; 45(4):385-99. PubMed ID: 16584285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Semi solid matrix formulations of meloxicam and tenoxicam: an in vitro and in vivo evaluation.
    Alladi S; Shastri NR
    Arch Pharm Res; 2015; 38(5):801-12. PubMed ID: 24752862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigations into the use of pregelatinised starch to develop powder-filled hard capsules.
    Gohil UC; Podczeck F; Turnbull N
    Int J Pharm; 2004 Nov; 285(1-2):51-63. PubMed ID: 15488679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multi-Compartmental Dissolution Method, an Efficient Tool for the Development of Enhanced Bioavailability Formulations Containing Poorly Soluble Acidic Drugs.
    Katona MT; Nagy-Katona L; Szabó R; Borbás E; Tonka-Nagy P; Takács-Novák K
    Pharmaceutics; 2023 Feb; 15(3):. PubMed ID: 36986614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pre-clinical and clinical evaluation of solution and soft gelatin capsule formulations for a BCS class 3 compound with atypical physicochemical properties.
    Ramsay-Olocco K; Alexandrova L; Nellore R; Killion R; Li L; Coen P; Ho Q; Jung D; Rocha C
    J Pharm Sci; 2004 Sep; 93(9):2214-21. PubMed ID: 15295782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improvements in soft gelatin capsule sample preparation for USP-based simethicone FTIR analysis.
    Hargis AD; Whittall LB
    J Pharm Biomed Anal; 2013 Feb; 74():223-6. PubMed ID: 23245254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cross-linking of hard gelatin carbamazepine capsules: effect of dissolution conditions on in vitro drug release.
    Marchais H; Cayzeele G; Legendre JY; Skiba M; Arnaud P
    Eur J Pharm Sci; 2003 Jun; 19(2-3):129-32. PubMed ID: 12791415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enzymes in the dissolution testing of gelatin capsules.
    Marques MR
    AAPS PharmSciTech; 2014 Dec; 15(6):1410-6. PubMed ID: 24942315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determination of the optimal amount of water in liquid-fill masses for hard gelatin capsules by means of texture analysis and experimental design.
    Kuentz M; Röthlisberger D
    Int J Pharm; 2002 Apr; 236(1-2):145-52. PubMed ID: 11891078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of dissolution profiles of acetaminophen beads using artificial neural networks.
    Peng Y; Geraldrajan M; Chen Q; Sun Y; Johnson JR; Shukla AJ
    Pharm Dev Technol; 2006; 11(3):337-49. PubMed ID: 16895844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design and statistical optimization of osmotically driven capsule based on push-pull technology.
    Shaikh W; Deshmukh PK; Patil GB; Chatap VK; Bari SB
    Pharm Dev Technol; 2013; 18(2):515-24. PubMed ID: 23033881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of Oromucosal Dosage Forms by Combining Electrospinning and Inkjet Printing.
    Palo M; Kogermann K; Laidmäe I; Meos A; Preis M; Heinämäki J; Sandler N
    Mol Pharm; 2017 Mar; 14(3):808-820. PubMed ID: 28195483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.